A study to evaluate imaging changes by three-dimensional nail imaging by optical coherence tomography in patients with nail psoriasis following 6 month-therapy with Apremilast

Trial Profile

A study to evaluate imaging changes by three-dimensional nail imaging by optical coherence tomography in patients with nail psoriasis following 6 month-therapy with Apremilast

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2017

At a glance

  • Drugs Apremilast (Primary)
  • Indications Plaque psoriasis; Psoriatic arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jun 2017 New trial record
    • 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top